Your Federal Quarterly Tax Payments are due April 15th Get Help Now >>

Sappi: corporate overview by xdKhg06

VIEWS: 0 PAGES: 14

									Sappi: corporate
overview



        January 2010
Group overview




   2 Fine Paper mills
   1 Specialty Paper mill       9 Fine Paper mills
   5 Sales offices              17 Sales offices
                                                      1 Fine Paper mill JV
      1 Sales office                                  4 Sales offices
                            1 Sales office


                            3 Fine Paper mills
                            5 Forest Products mills
                            10 Sales offices                 1 Sales office
         1 Sales office




                                                                              2
Sappi Limited - who are we today?


 We are the world’s leading producer of high quality coated fine paper
   used in printing everything from art books to quality magazines to wine labels.
  (USA, Europe, South Africa, China JV)

 We also produce a range of business paper, coated and uncoated speciality
  paper and casting release paper. (USA, Europe, SA)

 We are the largest and lowest cost producer of the chemical cellulose pulp
  used to produce viscose fiber. (SA – 100% export)

 We manufacture on four continents and have 40 sales offices around
  the globe, supplying paper and pulp to customers in over 100 countries.

 We employ over 15,600 people and achieved an annual turnover of US$5.369
  million (2009)

 We are listed on the stock exchanges of Johannesburg and New York.

                                                                                     3
Fine paper mills in South Africa




                                                        Enstra Mill
                                                       200,000 tons
                                                    uncoated fine paper
                                                     105,000 tons pulp




         Adamas Mill                                  Stanger Mill
         40,000 tons                                  110,000 tons
      uncoated fine paper                           coated fine paper
                                                       and tissue
                                                    60,000 tons pulp



                                   Total fine paper capacity
                                   in SA: 350,000 tons/year

                                                                          4
Forest Product operations in Southern Africa


    Plantations in Mpumalanga,                               Ngodwana
   Kwa Zulu Natal and Swaziland:                           510,000 tons pulp
 527,000ha land - 380,000ha planted                        240,000 tons kraft
                                                             140,000 tons
                                                               newsprint




                                                         Tugela
   Cape Kraft                                        390,000 tons kraft
 60,000 tons kraft                   Saiccor
                                                     350,000 tons pulp
                                   800,000 tons
                                chemical cellulose
                                 (dissolving pulp)

                                                                                5
Corporate Social Responsibility:
community development


                                              Refurbished Sappi
                                              Head Office and
                                              Piazza


            Various projects: Braamfontein rejuvenation




                                                                  6
TB in Sappi
                              Number of TB cases treated at the Sappi clinics


180
                                                                                          176


160


140


120
                                        115

                 97
100                      92
                                                      79                           78
 80

                                                                    60
 60

         38
 40
                                                                                                   16
 20


 0
      2002    2003    2004            2005         2006          2007           2008    2009    2010



                                                                                                        7
                                   Disease profile of the 3 funds from 01/10/00 - 31/6/07

60%
                                                 57%


50%
                                                 48%



40%




30%                                              29%




20%
         19%
                                                                                                                         17%
         15%
                                                                                                                                    12%
                                                                                                            11%
10%                                                                                                         9%
                    8%                                                                                                              9%
                                                                                                                                    8%
                                                                                                 7%
                                                                                                 6%
         6%                                                                                                 6%
                                                                                5%
                                       4%                                       4%
                                                                                3%               4%                                           4%
                    2%        3%
                              2%       3%                                                                                3%
                                                                2%                                                       2%                   2%
0%                            0%                                1%
                                                                0%                                                                            0%
      Neuro    Ca        Vision    Pulm.      AIDS         Psychotic        Back          Diabetes    Orthopedic   Depression   Cardio    Renal

                                                       Pension         PPAWUW        Provident




                                                                                                                                                   8
Sappi Manage TB


 Centre of excellence:


   Sappi Sister obtain the sputum sample

   Sappi Sister submit sample to the DoH lab

   Sappi Sister receive the results within 3-4 days

   DoH liaise with Sappi sister regarding treatment

   Sappi Sister initiate DOT and monitor the patient for duration of treatment.

   Partnership between Sappi and DoH




                                                                                   9
 Situation in most of the Units:


   Patient refer to local clinic with long waiting lists – loose a day of work

   Wait 1-2-3 weeks for results – numerous phone calls, staff turnover

   Patient to clinic where treatment is initiated – little to no communication with
    DoH

   DOT: Never sure what DoH has implemented - Sappi implement another
    system. Cause confusion.

   Repeat medication collection: patient loose each time a day from work.

   Sputum results: Again communication breakdown




                                                                                       10
 Action required:


    Sappi to initiate partnership with DoH.

    Training of health personnel

    Re-launch TB awareness programmes

    Implement DOT

    TB testing cumbersome and time consuming

    Clinics safer places




                                                11
12
13
www.sappi.com




                14

								
To top